Home Healthcare IT Anti-Rheumatics Market Size & Share , Growth, Demand Trends Forecast [2031]

Anti-Rheumatics Market Size, Share & Trends Analysis Report By Drug Class (Disease Modifying Anti-Rheumatic Drugs, Nonsteroidal Anti-inflammatory Drugs, Corticosteroids, Uric Acid Drugs, Others), By Type (Prescription-Based Drugs, Over-the-Counter Drugs) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRHI55734DR
Last Updated : 17,Jan 2024
Author : Straits Research
Starting From
USD 1850
Buy Now

Market Segmentation

  1. Anti-Rheumatics Market, By Drug Class (2021-2031)
    1. Disease Modifying Anti-Rheumatic Drugs
    2. Nonsteroidal Anti-inflammatory Drugs
    3. Corticosteroids
    4. Uric Acid Drugs
    5. Others
  2. Anti-Rheumatics Market, By Type (2021-2031)
    1. Prescription-Based Drugs
    2. Over-the-Counter Drugs
    1. North America
      1. North America Anti-Rheumatics Market, By Drug Class
        1. Disease Modifying Anti-Rheumatic Drugs
          1. Nonsteroidal Anti-inflammatory Drugs
            1. Corticosteroids
              1. Uric Acid Drugs
                1. Others
                2. North America Anti-Rheumatics Market, By Type
                  1. Prescription-Based Drugs
                    1. Over-the-Counter Drugs
                    2. U.S.
                      1. U.S. Anti-Rheumatics Market, By Drug Class
                        1. Disease Modifying Anti-Rheumatic Drugs
                          1. Nonsteroidal Anti-inflammatory Drugs
                            1. Corticosteroids
                              1. Uric Acid Drugs
                                1. Others
                                2. U.S. Anti-Rheumatics Market, By Type
                                  1. Prescription-Based Drugs
                                    1. Over-the-Counter Drugs
                                  2. Canada
                                3. Europe
                                  1. Europe Anti-Rheumatics Market, By Drug Class
                                    1. Disease Modifying Anti-Rheumatic Drugs
                                      1. Nonsteroidal Anti-inflammatory Drugs
                                        1. Corticosteroids
                                          1. Uric Acid Drugs
                                            1. Others
                                            2. Europe Anti-Rheumatics Market, By Type
                                              1. Prescription-Based Drugs
                                                1. Over-the-Counter Drugs
                                                2. U.K.
                                                  1. U.K. Anti-Rheumatics Market, By Drug Class
                                                    1. Disease Modifying Anti-Rheumatic Drugs
                                                      1. Nonsteroidal Anti-inflammatory Drugs
                                                        1. Corticosteroids
                                                          1. Uric Acid Drugs
                                                            1. Others
                                                            2. U.K. Anti-Rheumatics Market, By Type
                                                              1. Prescription-Based Drugs
                                                                1. Over-the-Counter Drugs
                                                              2. Germany
                                                              3. France
                                                              4. Spain
                                                              5. Italy
                                                              6. Russia
                                                              7. Nordic
                                                              8. Benelux
                                                              9. Rest of Europe
                                                            3. APAC
                                                              1. APAC Anti-Rheumatics Market, By Drug Class
                                                                1. Disease Modifying Anti-Rheumatic Drugs
                                                                  1. Nonsteroidal Anti-inflammatory Drugs
                                                                    1. Corticosteroids
                                                                      1. Uric Acid Drugs
                                                                        1. Others
                                                                        2. APAC Anti-Rheumatics Market, By Type
                                                                          1. Prescription-Based Drugs
                                                                            1. Over-the-Counter Drugs
                                                                            2. China
                                                                              1. China Anti-Rheumatics Market, By Drug Class
                                                                                1. Disease Modifying Anti-Rheumatic Drugs
                                                                                  1. Nonsteroidal Anti-inflammatory Drugs
                                                                                    1. Corticosteroids
                                                                                      1. Uric Acid Drugs
                                                                                        1. Others
                                                                                        2. China Anti-Rheumatics Market, By Type
                                                                                          1. Prescription-Based Drugs
                                                                                            1. Over-the-Counter Drugs
                                                                                          2. Korea
                                                                                          3. Japan
                                                                                          4. India
                                                                                          5. Australia
                                                                                          6. Singapore
                                                                                          7. Taiwan
                                                                                          8. South East Asia
                                                                                          9. Rest of Asia-Pacific
                                                                                        3. Middle East and Africa
                                                                                          1. Middle East and Africa Anti-Rheumatics Market, By Drug Class
                                                                                            1. Disease Modifying Anti-Rheumatic Drugs
                                                                                              1. Nonsteroidal Anti-inflammatory Drugs
                                                                                                1. Corticosteroids
                                                                                                  1. Uric Acid Drugs
                                                                                                    1. Others
                                                                                                    2. Middle East and Africa Anti-Rheumatics Market, By Type
                                                                                                      1. Prescription-Based Drugs
                                                                                                        1. Over-the-Counter Drugs
                                                                                                        2. UAE
                                                                                                          1. UAE Anti-Rheumatics Market, By Drug Class
                                                                                                            1. Disease Modifying Anti-Rheumatic Drugs
                                                                                                              1. Nonsteroidal Anti-inflammatory Drugs
                                                                                                                1. Corticosteroids
                                                                                                                  1. Uric Acid Drugs
                                                                                                                    1. Others
                                                                                                                    2. UAE Anti-Rheumatics Market, By Type
                                                                                                                      1. Prescription-Based Drugs
                                                                                                                        1. Over-the-Counter Drugs
                                                                                                                      2. Turkey
                                                                                                                      3. Saudi Arabia
                                                                                                                      4. South Africa
                                                                                                                      5. Egypt
                                                                                                                      6. Nigeria
                                                                                                                      7. Rest of MEA
                                                                                                                    3. LATAM
                                                                                                                      1. LATAM Anti-Rheumatics Market, By Drug Class
                                                                                                                        1. Disease Modifying Anti-Rheumatic Drugs
                                                                                                                          1. Nonsteroidal Anti-inflammatory Drugs
                                                                                                                            1. Corticosteroids
                                                                                                                              1. Uric Acid Drugs
                                                                                                                                1. Others
                                                                                                                                2. LATAM Anti-Rheumatics Market, By Type
                                                                                                                                  1. Prescription-Based Drugs
                                                                                                                                    1. Over-the-Counter Drugs
                                                                                                                                    2. Brazil
                                                                                                                                      1. Brazil Anti-Rheumatics Market, By Drug Class
                                                                                                                                        1. Disease Modifying Anti-Rheumatic Drugs
                                                                                                                                          1. Nonsteroidal Anti-inflammatory Drugs
                                                                                                                                            1. Corticosteroids
                                                                                                                                              1. Uric Acid Drugs
                                                                                                                                                1. Others
                                                                                                                                                2. Brazil Anti-Rheumatics Market, By Type
                                                                                                                                                  1. Prescription-Based Drugs
                                                                                                                                                    1. Over-the-Counter Drugs
                                                                                                                                                  2. Mexico
                                                                                                                                                  3. Argentina
                                                                                                                                                  4. Chile
                                                                                                                                                  5. Colombia
                                                                                                                                                  6. Rest of LATAM

                                                                                                                                              Related Reports

                                                                                                                                              Global Report
                                                                                                                                              The global bispecific antibodies market size was valued at USD 8.2 billion in 2023 and is projected to reach a value of USD 224.6 billion by 2032, registering a CAGR of 44.4% during the forecast period (2024-2032). The rise in cancer incidence is a c
                                                                                                                                              Buy Now
                                                                                                                                              Global Report
                                                                                                                                              The global X-Ray Inspection System Market size was valued at USD 734.5 Million in 2022 and is projected to reach USD 1231.3 Million by 2031, registering a CAGR of 6.6% during the forecast period (2023-2031). The rising awareness of the bene
                                                                                                                                              Buy Now
                                                                                                                                              Global Report
                                                                                                                                              Inflight Catering Market Size and Trends The global inflight catering market size was valued at USD 13.62 billion in 2023. It is projected to reach from USD 15.16 billion in 2024 to USD 35.75 billion by 2032, growing at a CAGR of 11.32% during the f
                                                                                                                                              Buy Now
                                                                                                                                              Global Report
                                                                                                                                              The global bladder scanners market size was valued at USD 141.70 million in 2022. It is projected to reach USD 232.38 million by 2031, growing at a CAGR of 5.65% during the forecast period (2023-2031). This is because many people globally have u
                                                                                                                                              Buy Now
                                                                                                                                              Global Report
                                                                                                                                              The global hair removal wax market size was valued at USD 13,110 million in 2022. It is estimated to reach USD 20,228 million by 2031, growing at a CAGR of 4.9% during the forecast period (2023–2031). Highlights Soft wax
                                                                                                                                              Buy Now

                                                                                                                                              Purchase Benefits

                                                                                                                                              • Eligible for a free updated report next year
                                                                                                                                              • Completely customizable scope
                                                                                                                                              • 30% discount on your next purchase
                                                                                                                                              • Dedicated account manager
                                                                                                                                              • Query resolution within 24 hours
                                                                                                                                              • Permission to print the report


                                                                                                                                              We are featured on :